David Altarac - Net Worth and Insider Trading
David Altarac Net Worth
The estimated net worth of David Altarac is at least $101,268 dollars as of 2024-12-26. David Altarac is the Chief Medical Officer of Entasis Therapeutics Holdings Inc and owns about 46,241 shares of Entasis Therapeutics Holdings Inc (ETTX) stock worth over $101,268. Details can be seen in David Altarac's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that David Altarac has not made any transactions after 2021-10-19 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of David Altarac
David Altarac Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, David Altarac owns 1 companies in total, including Entasis Therapeutics Holdings Inc (ETTX) .
Click here to see the complete history of David Altarac’s form 4 insider trades.
Insider Ownership Summary of David Altarac
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| ETTX | Entasis Therapeutics Holdings Inc | 2021-10-19 | Chief Medical Officer |
David Altarac Latest Holdings Summary
David Altarac currently owns a total of 1 stock. David Altarac owns 46,241 shares of Entasis Therapeutics Holdings Inc (ETTX) as of October 19, 2021, with a value of $101,268.
Latest Holdings of David Altarac
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| ETTX | Entasis Therapeutics Holdings Inc | 2021-10-19 | 46,241 | 2.19 | 101,268 |
Holding Weightings of David Altarac
David Altarac Form 4 Trading Tracker
According to the SEC Form 4 filings, David Altarac has made a total of 1 transactions in Entasis Therapeutics Holdings Inc (ETTX) over the past 5 years, including 0 buys and 1 sells. The most-recent trade in Entasis Therapeutics Holdings Inc is the sale of 3,759 shares on October 19, 2021, which brought David Altarac around $11,991.
Insider Trading History of David Altarac
- 1
David Altarac Trading Performance
David Altarac Ownership Network
David Altarac Owned Company Details
What does Entasis Therapeutics Holdings Inc do?
Who are the key executives at Entasis Therapeutics Holdings Inc?
David Altarac is the Chief Medical Officer of Entasis Therapeutics Holdings Inc. Other key executives at Entasis Therapeutics Holdings Inc include 10 percent owner Theravance Inc , VP & Principal Fin & Acct Off Kristie Ann Wagner , and Chief Development Officer John Patrick Mueller .
Entasis Therapeutics Holdings Inc (ETTX) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of Entasis Therapeutics Holdings Inc (ETTX) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Entasis Therapeutics Holdings Inc (ETTX) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Entasis Therapeutics Holdings Inc (ETTX)'s detailed insider trading history can be found in Insider Trading Tracker table.
Entasis Therapeutics Holdings Inc Insider Transactions
David Altarac Mailing Address
Above is the net worth, insider trading, and ownership report for David Altarac. You might contact David Altarac via mailing address: 35 Gatehouse Drive Waltham Ma 02451.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
